CompletedNot Applicable

Quality of Life in Patients Undergoing Total Pelvic Exenteration

United States94 participantsStarted 2005-01

Plain-language summary

The purpose of this study is to learn more about the personal experiences of patients who are treated with pelvic exenteration surgery. Pelvic exenteration is a surgical procedure in which the pelvic organs including the reproductive organs, bladder and/or rectum are removed. We would like to understand more about the physical, emotional, educational, and sexual needs of patients who are treated with this surgery. We will use what we learn from this study to help find better ways of preparing patients for this type of surgery. This will also allow us to be more helpful to patients' needs after surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients (male and female) who are scheduled to undergo total, anterior or posterior pelvic exenteration for pelvic malignancies arising in gynecologic, colorectal or urologic organs are eligible for participation in the study. Anterior or posterior pelvic exenteration must involve formation of a permanent ostomy (urostomy or colostomy). * Participants must be able to speak and read English proficiently. * Participants must be able to provide written informed consent. * Patients must be 18 years of age or older to enroll. Exclusion Criteria: * Subjects may be excluded or withdrawn from the study based on the following criteria. * Development of a cognitive or psychiatric deficit resulting in an inability to provide meaningful informed consent * Inability to speak or read in English.

What they're measuring

To characterize the extent of physical and psychological stress, and overall quality of life in patients undergoing total, anterior or posterior pelvic exenteration.

Timeframe: conclusion of study

Trial details

NCT IDNCT00597805

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-12